Researcher to Explore Kidney Diseases’ Effects on Bone

Susan M. Ott, MD

/kidneynews/8_10_11/34b/graphic/34bf1.jpg

Susan M. Ott, MD, will describe the “Pathophysiology of Renal Osteodystrophy” in the Jack W. Coburn, MD, Endowed Lectureship on Sunday, Nov. 20. Dr. Ott is professor of medicine at the University of Washington. She performed her first research with Dr. Donald Sherrard and Dr. Jack Coburn, investigating the effect of aluminum on renal osteodystrophy. Other studies have involved bone density measurements, bone histomorphometry, medical treatments for osteoporosis, effects of reproduction on the skeleton, and long-term effects of bisphosphonates.

Dr. Ott served on data safety and monitoring committees for the National Institutes of Health’s clinical nutrition and bone trials. She also participated on the KDIGO (Kidney Disease: Improving Global Outcomes) international committee that developed a clinical guideline for treatment of the mineral and bone disorder aspects of chronic kidney disease.

She was on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Endocrinology and Metabolism. She served on the council of the American Society of Bone and Mineral Research. Among her honors, she received a clinical investigator award from the National Institutes of Health and a young investigator award from the International Symposium on Osteoporosis.

Dr. Ott attended medical school at the University of Washington and residency training at the University of California at Davis. She returned to the University of Washington for a fellowship during the last year that Dr. Belding Scribner was chairman of nephrology.

October/November 2016  (Vol 8, Issue 10/11)